1440-1754/asset/JPC_left.gif?v=1&s=750bb849bea4b02c72fa4eb51aaa2f530870d8e7)
1440-1754/asset/JPC_right.gif?v=1&s=0124068dd0fd9a386351d49755398632482cce80)
Heads Up
You have free access to this content
Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study)
Article first published online: 16 JAN 2013
DOI: 10.1111/jpc.12048
© 2013 The Authors. Journal of Paediatrics and Child Health © 2013 Paediatrics and Child Health Division (Royal Australasian College of Physicians)
Additional Information
How to Cite
(2013), Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study). Journal of Paediatrics and Child Health, 49: 79–80. doi: 10.1111/jpc.12048
Publication History
- Issue published online: 16 JAN 2013
- Article first published online: 16 JAN 2013
References
- 1, , et al. Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial. Lancet; 379: 1613–1620.
- 2, , et al. Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease. N. Engl J. Med. 2007; 356: 663–675.
- 3, . Management of Kawasaki disease: corticosteroids revisited. Lancet; 379: 1571–1572.
- 4, , et al. Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance. J. Pediatr. 2011; 158: 831–835.